Skip to main content
. Author manuscript; available in PMC: 2024 Feb 1.
Published in final edited form as: Pain. 2022 May 23;164(2):305–315. doi: 10.1097/j.pain.0000000000002700

Table 3.

Descriptive summary of the clinical trial participants

Variable Time Point Overall Group A Group B Group C Group D
Worst Pain Intensity Day 1 Mean ± SdtDev 0.2 ± 0.7 0.1 ± 0.4 0.2 ± 0.6 0.2 ± 0.6 0.4 ± 1.0
Median (Min, Max) 0.0 (0.0, 5.0) 0.0 (0.0, 2.0) 0.0 (0.0, 3.0) 0.0 (0.0, 3.0) 0.0 (0.0, 5.0)
Day 2 Mean ± SdtDev 3.0 ± 2.0 2.9 ± 2.1 3.2 ± 2.1 2.9 ± 1.9 3.1 ± 2.0
Median (Min, Max) 3.0 (0.0, 8.0) 3.0 (0.0, 8.0) 3.0 (0.0, 8.0) 3.0 (0.0, 7.0) 3.0 (0.0, 8.0)
Day 3 Mean ± SdtDev 3.0 ± 2.0 2.8 ± 2.2 3.1 ± 2.0 2.8 ± 1.9 3.3 ± 2.0
Median (Min, Max) 3.0 (0.0, 9.0) 2.0 (0.0, 9.0) 3.0 (0.0, 8.0) 2.0 (0.0, 7.0) 3.0 (0.0, 8.0)
Day 4 Mean ± SdtDev 2.3 ± 2.0 2.3 ± 2.3 2.3 ± 2.0 2.3 ± 1.9 2.2 ± 1.8
Median (Min, Max) 2.0 (0.0, 10.0) 2.0 (0.0, 10.0) 2.0 (0.0, 9.0) 2.0 (0.0, 8.0) 2.0 (0.0, 7.0)
Day 5 Mean ± SdtDev 1.4 ± 1.6 1.6 ± 2.0 1.6 ± 1.9 1.1 ± 1.3 1.3 ± 1.3
Median (Min, Max) 1.0 (0.0, 8.0) 1.0 (0.0, 7.0) 1.0 (0.0, 8.0) 1.0 (0.0, 5.0) 1.0 (0.0, 6.0)
Current Pain Intensity Day 1 Mean ± SdtDev 0.1 ± 0.4 0.1 ± 0.2 0.1 ± 0.5 0.1 ± 0.3 0.2 ± 0.6
Median (Min, Max) 0.0 (0.0, 3.0) 0.0 (0.0, 1.0) 0.0 (0.0, 2.0) 0.0 (0.0, 2.0) 0.0 (0.0, 3.0)
Day 2 Mean ± SdtDev 1.9 ± 1.8 1.8 ± 1.8 2.1 ± 2.0 1.7 ± 1.6 2.0 ± 1.8
Median (Min, Max) 1.0 (0.0, 8.0) 1.0 (0.0, 8.0) 2.0 (0.0, 8.0) 1.0 (0.0, 6.0) 2.0 (0.0, 7.0)
Day 3 Mean ± SdtDev 1.7 ± 1.9 1.6 ± 2.0 1.6 ± 1.8 1.5 ± 1.8 2.0 ± 1.9
Median (Min, Max) 1.0 (0.0, 9.0) 1.0 (0.0, 9.0) 1.0 (0.0, 7.0) 1.0 (0.0, 8.0) 1.0 (0.0, 8.0)
Day 4 Mean ± SdtDev 1.1 ± 1.6 1.3 ± 2.0 1.3 ± 1.7 0.9 ± 1.4 0.9 ± 1.3
Median (Min, Max) 1.0 (0.0, 9.0) 0.5 (0.0, 9.0) 1.0 (0.0, 8.0) 0.5 (0.0, 7.0) 0.0 (0.0, 6.0)
Day 5 Mean ± SdtDev 0.6 ± 1.5 0.8 ± 1.7 0.7 ± 1.4 0.5 ± 1.8 0.4 ± 0.8
Median (Min, Max) 0.0 (0.0, 10.0) 0.0 (0.0, 10.0) 0.0 (0.0, 7.0) 0.0 (0.0, 10.0) 0.0 (0.0, 4.0)
Q-Dash Score Day 1 Mean ± SdtDev 3.8 ± 5.6 4.7 ± 6.5 3.1 ± 4.8 3.7 ± 5.3 3.9 ± 5.7
Median (Min, Max) 2.3 (0.0, 34.1) 2.3 (0.0, 34.1) 0.0 (0.0, 15.9) 0.0 (0.0, 20.5) 2.3 (0.0, 29.5)
Day 2 Mean ± SdtDev 13.0 ± 12.0 14.2 ± 12.5 13.2 ± 12.7 11.4 ± 11.5 13.1 ± 11.2
Median (Min, Max) 9.1 (0.0, 50.0) 9.1 (0.0, 47.7) 9.1 (0.0, 47.7) 9.1 (0.0, 50.0) 9.1 (0.0, 45.5)
Day 3 Mean ± SdtDev 15.0 ± 13.5 16.4 ± 15.3 15.1 ± 14.0 13.4 ± 11.8 15.2 ± 13.1
Median (Min, Max) 11.4 (0.0, 70.5) 11.4 (0.0, 70.5) 11.4 (0.0, 68.2) 11.4 (0.0, 47.7) 9.1 (0.0, 54.5)
Day 4 Mean ± SdtDev 12.9 ± 12.6 14.9 ± 14.2 13.7 ± 14.3 11.2 ± 10.9 12.2 ± 10.7
Median (Min, Max) 9.1 (0.0, 70.5) 11.4 (0.0, 61.4) 9.1 (0.0, 70.5) 9.1 (0.0, 45.5) 9.1 (0.0, 45.5)
Day 5 Mean ± SdtDev 9.8 ± 10.6 11.4 ± 12.9 10.5 ± 12.4 8.2 ± 8.5 9.4 ± 8.3
Median (Min, Max) 6.8 (0.0, 59.1) 6.8 (0.0, 59.1) 6.8 (0.0, 59.1) 5.7 (0.0, 29.5) 8.0 (0.0, 36.4)

Table Key: Group A = Placebo and Psychologic Intervention; Group B = Placebo and General Education; Group C = Propranolol and Psychologic Intervention; Group D = Propranolol and General Education.